Merit medical's wrapsody™ arteriovenous access efficacy (wave) pivotal study completes enrollment

South jordan, utah, aug. 03, 2023 (globe newswire) -- merit medical systems, inc. (nasdaq: mmsi), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its wrapsody arteriovenous access efficacy (wave) pivotal study. merit's wave study is a prospective, randomized, controlled, multicenter study comparing the merit wrapsody cell-impermeable endoprosthesis (cie) to percutaneous transluminal angioplasty for treatment of stenosis/occlusion in the venous outflow circuit in patients undergoing hemodialysis.
MMSI Ratings Summary
MMSI Quant Ranking